1. Home
  2. IBRX vs HUT Comparison

IBRX vs HUT Comparison

Compare IBRX & HUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ImmunityBio Inc.

IBRX

ImmunityBio Inc.

N/A

Current Price

$6.09

Market Cap

8.2B

Sector

Health Care

ML Signal

N/A

Logo Hut 8 Corp.

HUT

Hut 8 Corp.

N/A

Current Price

$46.58

Market Cap

8.2B

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
IBRX
HUT
Founded
2014
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Finance: Consumer Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
8.2B
8.2B
IPO Year
2015
2023

Fundamental Metrics

Financial Performance
Metric
IBRX
HUT
Price
$6.09
$46.58
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
23
Target Price
$14.25
★ $127.70
AVG Volume (30 Days)
★ 12.0M
5.6M
Earning Date
11-09-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 38.71
N/A
EPS
★ N/A
N/A
Revenue
$113,288,000.00
★ $235,118,000.00
Revenue This Year
$99.98
$26.73
Revenue Next Year
$108.29
$91.69
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 668.31
44.79
52 Week Low
$1.95
$34.18
52 Week High
$12.43
$140.80

Technical Indicators

Market Signals
Indicator
IBRX
HUT
Relative Strength Index (RSI) 36.40 35.59
Support Level N/A $44.25
Resistance Level $8.62 $60.58
Average True Range (ATR) 0.57 6.46
MACD -0.10 0.34
Stochastic Oscillator 10.19 16.66

Price Performance

Historical Comparison
IBRX
HUT

About IBRX ImmunityBio Inc.

ImmunityBio Inc is a biotechnology company focused on developing and commercializing next-generation immunotherapies designed to activate the patient's immune system and provide durable protection against cancer and infectious diseases. Its approach harnesses both the adaptive and innate immune systems with the Cancer BioShield platform. The platform is built around the proprietary IL-15 superagonist ANKTIVA (nogapendekin alfa inbakicept) and is supported by a portfolio that includes adenovirus-vectored vaccines, NK-cell therapies, and additional immunomodulators. The company operates in the United States and Europe, with the majority of its revenue coming from the United States.

About HUT Hut 8 Corp.

Hut 8 Corp is an energy infrastructure platform that integrates power, digital infrastructure, and compute at scale to fuel next-generation, energy-intensive use cases. The company has four reportable business segments: Power, Digital Infrastructure, Compute, and Other. It derives maximum revenue from the Compute segment which consists of Bitcoin Mining, GPU-as-a-Service, and Data Center Cloud operations. Its geographical segments include the United States and Canada, of which it generates the majority of revenue from the United States.

Share on Social Networks: